AbCellera Biologics (ABCL) EBIT (2020 - 2026)
AbCellera Biologics (ABCL) posted EBIT of -$62.78 million for Q2 2026, compared with -$49.59 million a year earlier.
Powered by 
Analysis
AbCellera Biologics (ABCL) EBIT (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at AbCellera Biologics was -$225.16 million; for FY2025, it came in at -$217.1 million.
- In prior years, AbCellera Biologics' EBIT was -$314.77 million in FY2024, -$237.21 million in FY2023, $216.51 million in FY2022 (+5.9%) and $204.41 million in FY2021 (+31.0%).
- Quarterly EBIT has run from a low of -$93.66 million in Q3 2024 to a high of $224.95 million in Q1 2022 over five years.
- According to Business Quant data, EBIT for the three prior quarters was -$57.52 million (Q1 2026), -$28.58 million (Q4 2025) and -$76.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | AbCellera Biologics | 3.83 Bn | 3.29 Bn | - | -62.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -62.78 Mn |
| Mar 31, 2026 | -57.52 Mn |
| Dec 31, 2025 | -28.58 Mn |
| Sep 30, 2025 | -76.28 Mn |
| Jun 30, 2025 | -49.59 Mn |
| Mar 31, 2025 | -62.66 Mn |
| Dec 31, 2024 | -72.76 Mn |
| Sep 30, 2024 | -93.66 Mn |
| Jun 30, 2024 | -93.45 Mn |
| Mar 31, 2024 | -54.89 Mn |
| Dec 31, 2023 | -66.05 Mn |
| Sep 30, 2023 | -54.89 Mn |
| Jun 30, 2023 | -51.39 Mn |
| Mar 31, 2023 | -64.87 Mn |
| Dec 31, 2022 | -37.78 Mn |
| Sep 30, 2022 | 37.74 Mn |
| Jun 30, 2022 | -8.40 Mn |
| Mar 31, 2022 | 224.95 Mn |
| Dec 31, 2021 | 81.55 Mn |
| Sep 30, 2021 | -28.10 Mn |
API Access
AbCellera Biologics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();